Reaction Details |
| Report a problem with these data |
Target | Bromodomain-containing protein 9 [134-239] |
---|
Ligand | BDBM310896 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | BRD9 AlphaLisa Binding Assay |
---|
IC50 | 25.0±n/a nM |
---|
Citation | Albrecht, BK; Bellon, SF; Burdick, DJ; Cote, A; Crawford, T; Dakin, LA; Hsiao-Wei Tsui, V; Hewitt, MC; LeBlanc, Y; Magnuson, SR; Nasveschuk, CG; Romero, AF; Tang, Y; Taylor, AM; Wang, S Therapeutic compounds and uses thereof US Patent US10150767 Publication Date 12/11/2018 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bromodomain-containing protein 9 [134-239] |
---|
Name: | Bromodomain-containing protein 9 [134-239] |
Synonyms: | BRD9 | BRD9 (aa 134-239) | BRD9_HUMAN |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 12286.22 |
Organism: | Homo sapiens (Human) |
Description: | Q9H8M2[134-239] |
Residue: | 106 |
Sequence: | AENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVAN
EYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSK
|
|
|
BDBM310896 |
---|
n/a |
---|
Name | BDBM310896 |
Synonyms: | 7-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one | US10150767, Example 12 |
Type | Small organic molecule |
Emp. Form. | C17H16N4O2 |
Mol. Mass. | 308.3345 |
SMILES | Cn1cc(-c2ccc3NC(=O)CCNc3c2)c2cc[nH]c2c1=O |
Structure |
|